B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells

Su-Yi Tseng(Johns Hopkins University), Mizuto Otsuji(Johns Hopkins University), Kevin Gorski(Johns Hopkins University), Xin Huang(Johns Hopkins University), Jill E. Slansky(Johns Hopkins University), Sara I. Pai(Johns Hopkins University), Ahmed Shalabi(Johns Hopkins University), Tahiro Shin(Johns Hopkins University), Drew M. Pardoll(Johns Hopkins University), Haruo Tsuchiya(Johns Hopkins University)
The Journal of Experimental Medicine
April 2, 2001
Cited by 859Open Access
Full Text

Abstract

Dendritic cells (DCs), unique antigen-presenting cells (APCs) with potent T cell stimulatory capacity, direct the activation and differentiation of T cells by providing costimulatory signals. As such, they are critical regulators of both natural and vaccine-induced immune responses. A new B7 family member, B7-DC, whose expression is highly restricted to DCs, was identified among a library of genes differentially expressed between DCs and activated macrophages. B7-DC fails to bind the B7.1/2 receptors CD28 and cytotoxic T lymphocyte-associated antigen (CTLA)-4, but does bind PD-1, a receptor for B7-H1/PD-L1. B7-DC costimulates T cell proliferation more efficiently than B7.1 and induces a distinct pattern of lymphokine secretion. In particular, B7-DC strongly costimulates interferon gamma but not interleukin (IL)-4 or IL-10 production from isolated naive T cells. These properties of B7-DC may account for some of the unique activity of DCs, such as their ability to initiate potent T helper cell type 1 responses.


Related Papers